Drug Device Combination Products Market to Expand at a CAGR of 11.95% to 2019 Due to Rise in Oncology Industry
ResearchMoz presents professional and in-depth study of "Global Drug Device Combination Products Market 2015-2019". Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine. Technavio's analysts forecast the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type: Drug eluting stent Prefilled s